Nina is the Global Segment Lead for Rare Disease and Clinical/Translational Research at PacBio, supporting WGS and targeted sequencing applications, clinical research and implementation, and tertiary software partnerships. She joined PacBio in 2021. She was previously doing Medical Genomics Research at Illumina where she supported pediatric rare disease analysis and health economic studies, as well as pharmacogenomics product development.

PhD in Pharmaceutical Sciences and Pharmacogenomics from UCSF, BS and MS in Biomedical Informatics from Stanford University.